Journal article
Surveillance in Germline TP53 Mutation Carriers Utilizing Whole-Body Magnetic Resonance Imaging
ML Ballinger, NJ Ferris, K Moodie, G Mitchell, S Shanley, PA James, DM Thomas
JAMA Oncology | AMER MEDICAL ASSOC | Published : 2017
Abstract
This prospective study of surveillance strategies uses a whole-body screening program, including whole-body magnetic resonance imaging, in carriers of germline mutations in TP53.
Grants
Awarded by Cancer Australia's Priority-driven Collaborative Cancer Research Scheme
Funding Acknowledgements
The Australasian Sarcoma Study Group provided indemnity cover for the study. Support was also received from the Johanna Sewell Research Foundation and Cancer Australia's Priority-driven Collaborative Cancer Research Scheme (APP1067094).